Abstract
These consensus guidelines have been developed by a group of Latin American experts in pain management, to point out patterns and make practical recommendations to guide the diagnosis, identify warning signs (yellow and red flags), and establish comprehensive medical management (pharmacologic and nonpharmacologic treatment) and monitoring plans for patients enduring neuropathic pain. From the viewpoint of pharmacologic management, drugs are classified into groups according to efficacy, availability/accessibility, and safety criteria. Drugs are recommended for use depending on the disease and particular circumstances of each patient, with an approach that favors multimodal treatment while taking into consideration the idiosyncrasies of medical practice in Latin America.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 261-281 |
| Number of pages | 21 |
| Journal | Journal of Pain and Palliative Care Pharmacotherapy |
| Volume | 23 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Anesthesiology and Pain Medicine
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Guidelines for the diagnosis and management of neuropathic pain: Consensus of a group of latin american experts'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver